Canadian Cannabis: 1 Sector Immune to the Stock Market Crash

Canadian cannabis stocks could be resistant to the market crash. Here’s why names like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are a buy.

edit Jars of marijuana

Image source: Getty Images

The past year has seen profound changes for Canadian cannabis stocks in general. The overall long-term consensus is that there’s room for about four or five big names at the top — but which four or five they might be has changed repeatedly. Cash runways are now just as important as profitability to investors. The market has begun to mature, even if it hasn’t exactly stabilized yet.

Canadian cannabis: the perfect industry for the “new normal?”

Imagine an industry that could beat the market crash — a brand-new industry, not yet regulated at the U.S. federal level. An outsider industry that could bring in revenue for every city in every state, an outperforming industry with proven popularity that could beat the market.

An industry that is simply waiting to be legalized stateside so that it can start generating taxable revenue. That industry exists: it’s cannabis.

It’s easy to look at pot stocks through the filter of the current public health crisis and see their losses as being symptomatic. However, Canadian cannabis stocks have proved remarkably resilient to the coronavirus market crash.

The TSX Composite Index is down 20% in the past month. But Canopy Growth is down 19.8%. Who would have thought that a pot stock could beat the TSX in a market crash?

Go long on market-disrupting cannabis stocks

Canadian cannabis has seen its headwinds. But they could be flipped around and turned into tailwinds by U.S. legalization. The growth would be phenomenal, and some of our biggest names are already in position to capitalize.

Look at Canopy Growth with its Acreage Holdings deal and Constellation Brands leadership. Look at the CBD capabilities of HEXO, Aphria, Cronos Group, and more.

However, as cannabis investors will know, the past year hasn’t been plain sailing even for popular Canadian cannabis stocks. Village Farms, for instance, fell out with joint venture Pure Sunfarms co-owner, Emerald Health Therapeutics over supply agreements.

The dispute was duly settled, though, with Village Farms eventually upping its majority stake in Pure Sunfarms to 57.4% during its fourth quarter.

However, no other cannabis stocks offer the same unique mix of safety and growth potential. Village Farms remains a world-class vegetable producer, and even produces some clean electricity.

With around 80% upside potential, the majority owner of Pure Sunfarms is a long-term buy. This quality cannabis name now commands a 13.5% market share in the dried flower space.

This popular Canadian cannabis name, operating out of British Columbia, is on track for huge upside. Its 13.5% market share for dried flower makes Village Farms a top name to watch.

It’s a canny play if you’re looking for a smaller-cap name with masses of growth potential. The stock has an exceptionally solid outlook thanks to low overheads and huge CBD growth potential.

The bottom line

Pure Sunfarms is steadily capturing market share in the dried flower market. Investors looking to buy on extreme weakness have a strong play in this low cost, large-scale producer right now.

Canopy, Aphria, and Cronos are also strong long-term buys for market dominance.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Village Farms International, Inc. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »